Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety Assessment of the 480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo SFA Lesions

NCT01403077 is registered in ClinicalTrials.gov with 480 Biomedical as lead sponsor.

NCT NCT01403077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01403077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety Assessment of the 480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo SFA Lesions
Lead sponsor
480 Biomedical
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2011
Completion date
October 31, 2015
Enrollment
46 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis of femoral artery, superficial femoral artery lesions